-
The impact of GLP-1 on Eating Disorders
Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 (glucagon-like peptide-1) receptor agonists – medications that were initially developed and FDA-approved to treat type 2 diabetes are also being used off-label for weight loss beyond medical need.. Wegovy, Ozempic, Mounjaro, Trulicity and other similar drugs work by…
-
Tips for Coping with Valentine’s Day When it isn’t all Roses and Chocolate
Valentine’s Day can be a challenging time for many, stirring up a range of emotions and expectations. Our very own, Dr. Eva Leighton, a licensed psychologist and expert in relationship dynamics, recently shared her valuable insights in an interview with Westfair Online. Dr. Leighton offers thoughtful, practical advice to help individuals cope with the pressures…
